Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy

• Published in: Diabetes, metabolic syndrome and obesity metabolic syndrome and obesity, 2021-04, Vol.14, p.1681-1693
• Main Authors: Song, Zhixia, Xiao, Chao, Jia, Xiaoli, Luo, Chunhua, Shi, Lang, Xia, Rong, Zhu, Jiefu, Zhang, Shizhong
• Format: Article
• Language: English
• Subjects: Alfacalcidol; Antibodies; Antigens; Autophagy; Calcifediol; calcitriol; China; Development and progression; Dextrose; Diabetes; Diabetic foot; Diabetic nephropathies; Diabetic nephropathy; Diet therapy; Diseases; Drug dosages; Glucose; Homeostasis; Immunohistochemistry; Kidney diseases; Laboratories; Medical colleges; Microscopy; Molecular biology; Original Research; podocyte; Proteins; Software; Streptozocin; Type 2 diabetes; Urine; Vitamin D; vitamin d receptor; Vitamin deficiency
• ISSN: 1178-7007; 1178-7007
• DOI: 10.2147/DMSO.S303018

The present study is to investigate the effect of vitamin D/Vitamin D Receptor (VDR) signaling on podocyte autophagy in diabetic nephropathy. Kidney tissue sections from patients with diabetic nephropathy and nontumor kidney were checked under electronic microscope and VDR immunohistochemistry. Diabetic rat models were induced by intraperitoneal injection of streptozotocin (STZ) (60 mg/kg). Calcitriol treatment was achieved by gavage at dose of 0.1μg/kg/d. Blood, urine and kidney tissue specimens were used for serum, urine biochemistry, histopathology and molecular biology testing. Podocyte cell line MPC-5 was cultured under hyperglycaemic conditions in the absence or presence of 100 nmol/L calcitriol to investigate podocyte injury and autophagy. VDR and autophagosomes in podocytes were significantly decreased in renal biopsy from patients with diabetic nephropathy, compared to healthy kidney tissue. Rats with STZ treatment developed typical diabetic kidney disease with low VDR expression. Calcitriol, the active form of vitamin D, could activate VDR and attenuate diabetic nephropathy including proteinuria and glomerular sclerosis. Calcitriol treatment also alleviated the podocyte foot process fusion, reduced podocyte injury marker desmin and preserved slit diaphragms proteins in diabetic nephropathy. Reduced LC3II/I, Beclin-1 and elevated p62 in renal homogenate and reduced autophagosomes and LC3II in podocytes indicated podocytes autophagy impairment in diabetic nephropathy. Whereas calcitriol treatment restored podocyte autophagy activities. In cultured podocytes, the protective effect of calcitriol against high glucose induced podocyte injury could be abated by autophagy inhibitor chloroquine. Our study delivered the evidence that calcitriol/VDR signaling attenuated diabetic nephropathy and podocytes injury by restoring podocytes autophagy. This finding may have potential implication for exploring protective mechanisms of calcitriol/VDR in diabetic nephropathy.